Propanc Biopharma, Inc. Increase (Decrease) in Derivative Liabilities
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2014-05-20
- Propanc Biopharma, Inc. increase (decrease) in derivative liabilities for the quarter ending 2014-03-31 was -$58.65K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 75 month | Increase (Decrease) in Derivative Liabilities 77 month |
|---|---|---|---|---|---|
| 2014-03-31 | -$58.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20 | -$27.02K 10-Q · filed 2014-05-20 | -$27.02K 10-Q · filed 2014-05-20 | ||
| 2013-12-31 | $31.63K 10-Q · filed 2014-02-14 | $31.63K 10-Q · filed 2014-02-14 |